NIKKEI 225
38,385.73 +29.67 (+0.08%) HANG SENG
19,073.71 -41.35 (-0.22%) CRUDE OIL
78.90 +0.88 (+1.13%) GOLD FUTURES
2,392.10 +32.20 (+1.36%) DOW
39,908.00 +349.89 (+0.88%) Bitcoin GBP
51,939.45 +3,367.25 (+6.93%)
AZN Jan 2025 37.500 call
| Previous close | 30.06 |
| Open | 29.98 |
| Bid | 38.55 |
| Ask | 39.25 |
| Strike | 37.50 |
| Expiry date | 2025-01-17 |
| Day's range | 29.98 - 30.06 |
| Contract range | N/A |
| Volume | |
| Open interest | 9 |
- Reuters
PRESS DIGEST-British Business - May 14
The following are the top stories on the business pages of British newspapers. - Anglo American rejected a raised takeover offer of 34 billion pounds ($42.67 billion) from BHP Group on Monday, saying the world's largest listed miner "continues to significantly undervalue" the company. - JPMorgan Chase has pledged a further 40 million pounds ($50.22 million) in philanthropic investments in the UK over five years in a sign of its increasing focus on Britain.
The TelegraphUK pharma giants pledge £430m investment in France after Macron charm offensive
Britain’s two biggest pharmaceutical companies have pledged £430m of investment in France after a charm offensive by Emmanuel Macron.
ZacksBristol Myers (BMY) Fails to Meet Goal in Opdivo NSCLC Study
Bristol Myers' (BMY) late-stage label-expanding study evaluating the Opdivo/Yervoy combination fails to meet the primary endpoint of progression-free survival in unresectable stage III NSCLC.
